
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 16, 2024, titled "Glenmark Pharmaceuticals Inc., USA launches Lacosamide Oral Solution, 10 mg/mL".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 16, 2024, titled "Glenmark Pharmaceuticals Inc., USA launches Lacosamide Oral Solution, 10 mg/mL".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals